Loading...
OTCM
BNKL
Market cap1kUSD
May 05, Last price  
0.00USD
Name

Bionik Laboratories Corp

Chart & Performance

D1W1MN
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
59.29%
Rev. gr., 5y
12.82%
Revenues
2m
+41.73%
7,0007,5005,2006,0000571,945987,4313,246,0382,153,3541,193,4301,273,7121,805,202
Net income
-5m
L-68.31%
-4,661-9,387-13,109-29,5281,036,148-3,936,574-14,728,789-10,556,094-24,934,748-13,958,153-15,608,602-4,946,024
CFO
-3m
L-18.32%
-4,250-8,069-14,609-13,204-4,747,836-6,992,313-7,710,862-9,232,411-9,063,554-4,623,886-4,147,287-3,387,314

Profile

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.
URL
https://www.bioniklabs.com/
IPO date
Jun 12, 2012
Employees
12
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
1,805
41.73%
Cost of revenue
6,630
Unusual Expense (Income)
NOPBT
(4,825)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
(4,825)
Net income
(4,946)
-68.31%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
22
Long-term debt
2,647
Deferred revenue
303
Other long-term liabilities
Net debt
2,241
Cash flow
Cash from operating activities
(3,387)
CAPEX
(9)
Cash from investing activities
(224)
Cash from financing activities
2,050
FCF
(4,138)
Balance
Cash
427
Long term investments
Excess cash
337
Stockholders' equity
(100,312)
Invested Capital
101,387
ROIC
ROCE
EV
Common stock shares outstanding
6,904
Price
0.40
 
Market cap
2,761
 
EV
5,003
EBITDA
(4,762)
EV/EBITDA
Interest
107
Interest/NOPBT